Menu

Odyssey Therapeutics, Inc. ODTX

Full chart Compare
Set alert

Price alert · ODTX

All alert types
20.62 USD +0.62 (+3.11%)

Nov 11, 2026, 2:50 PM EST

19.22 Day range 20.81
15.10 52-week range 29.05
YTD
+25.59%
1 year
+25.59%

Revenue & Expenses

Other Income → Expenses: $11.58MIncome Tax Benefit → Expenses: $927.00KExpenses → Selling, General & Admin: $37.52MExpenses → Research & Development: $126.62MGross Profit → Expenses: $2.98MRevenue → Gross Profit: $2.98MNet Loss → Expenses: $148.65MOther Income$11.58MIncome Tax Benefit$927.00KGross Profit$2.98MNet Loss$148.65MExpenses$164.13MSelling, General & Admin$37.52MResearch & Development$126.62MRevenue$2.98M

Latest period ending Dec 31, 2025 · select a line to chart its full history

ODTX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
2.98M4.47M
2.98M4.47M
-161.16M-135.22M
-148.65M-130.40M
-48.93-148.21
ODTX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
41.69M59.14M
269.79M197.44M
54.51M65.07M
27.11M31.01M
-488.28M-382.53M
ODTX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
-129.47M-117.47M
-103.94M96.78M
215.65M26.98M
-875.00K-764.00K
-17.45M6.34M